YI vs TDOC

For growth investors, Teladoc Health, Inc.

(TDOC) is the stronger pick with -1. 5% revenue growth year-over-year, versus -3. 7% for 111, Inc. (YI). Analysts rate Teladoc Health, Inc. (TDOC) a "Hold" — based on 42 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, 111, Inc.

(YI) delivered a total return of -95. 1%, compared to -95. 4% for Teladoc Health, Inc. (TDOC). Over 10 years, the gap is even starker: TDOC returned -38. 7% versus YI's -95. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), 111, Inc.

(YI) is the lower-risk stock at 0. 27β versus Teladoc Health, Inc. 's 1. 89β — meaning TDOC is approximately 594% more volatile than YI relative to the S&P 500. On balance sheet safety, 111, Inc. (YI) carries a lower debt/equity ratio of 67% versus 75% for Teladoc Health, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Teladoc Health, Inc.

(TDOC) is pulling ahead at -1. 5% versus -3. 7% for 111, Inc. (YI). On earnings-per-share growth, the picture is similar: 111, Inc. grew EPS 83. 9% year-over-year, compared to 80. 6% for Teladoc Health, Inc.. Over a 3-year CAGR, YI leads at 5. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

111, Inc.

(YI) is the more profitable company, earning -0. 4% net margin versus -7. 9% for Teladoc Health, Inc. — meaning it keeps -0. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: YI leads at 0. 0% versus -10. 4% for TDOC. At the gross margin level — before operating expenses — TDOC leads at 69. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, 111, Inc.

(YI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 27)). Teladoc Health, Inc. (TDOC) carries a higher beta of 1. 89 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (YI: -95. 6%, TDOC: -38. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.